Submucosal Injection of the RNA Oligonucleotide GUT-1 in Active Ulcerative Colitis Patients: A Randomized, Double-Blind, Placebo-Controlled Phase 2a Induction Trial.
- DOI
- 10.1093/ecco-jcc/jjad162
- Published
- 2024 Mar 1
- Container
- Journal of Crohn's & colitis
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/ecco-jcc/jjad162,
title = {Submucosal Injection of the RNA Oligonucleotide GUT-1 in Active Ulcerative Colitis Patients: A Randomized, Double-Blind, Placebo-Controlled Phase 2a Induction Trial.},
author = {Atreya R and Kühbacher T and Waldner MJ and Hirschmann S and Drvarov O and Abu Hashem R and Maaser C and Kucharzik T and Dinter J and Mertens J and Schramm C and Holler B and Mössner J and Suzuki K and Yokoyama J and Terai S and Uter W and Yoneyama H and Asakura H and Hibi T and Neurath MF},
year = {2024},
journal = {Journal of Crohn's \& colitis},
doi = {10.1093/ecco-jcc/jjad162},
url = {https://doi.org/10.1093/ecco-jcc/jjad162}
}RIS
TY - JOUR TI - Submucosal Injection of the RNA Oligonucleotide GUT-1 in Active Ulcerative Colitis Patients: A Randomized, Double-Blind, Placebo-Controlled Phase 2a Induction Trial. AU - Atreya R AU - Kühbacher T AU - Waldner MJ AU - Hirschmann S AU - Drvarov O AU - Abu Hashem R AU - Maaser C AU - Kucharzik T AU - Dinter J AU - Mertens J AU - Schramm C AU - Holler B AU - Mössner J AU - Suzuki K AU - Yokoyama J AU - Terai S AU - Uter W AU - Yoneyama H AU - Asakura H AU - Hibi T AU - Neurath MF PY - 2024 JO - Journal of Crohn's & colitis DO - 10.1093/ecco-jcc/jjad162 UR - https://doi.org/10.1093/ecco-jcc/jjad162 ER -
APA
R, A., T, K., MJ, W., S, H., O, D., R, A. H., C, M., T, K., J, D., J, M., C, S., B, H., J, M., K, S., J, Y., S, T., W, U., H, Y., H, A., T, H., & MF, N. (2024). Submucosal Injection of the RNA Oligonucleotide GUT-1 in Active Ulcerative Colitis Patients: A Randomized, Double-Blind, Placebo-Controlled Phase 2a Induction Trial.. Journal of Crohn's & colitis. https://doi.org/10.1093/ecco-jcc/jjad162
Source records
- pubmed · retrieved 2026-09-26T05:42:57.860Z